1-3 of 3
Keagan Casey
Close
Sort by
Journal Articles

Phase 1 Study of CD37-Directed CAR T Cells in Patients with Relapsed or Refractory CD37+ Hematologic Malignancies

Matthew J. Frigault, Yi-Bin Chen, Kathleen M.E. Gallagher, Nora K. Horick, Areej El-Jawahri, Irene Scarfò, Marc Wehrli, Lu Huang, Keagan Casey, Daniella Cook, Thomas Spitzer, Steven McAfee, Frederic I. Preffer, Myriam Armant, Kit L. Shaw, Heather Daley, Sarah Nikiforow, Jerome Ritz, Marcela V. Maus
Journal: Blood
Blood (2021) 138 (Supplement 1): 653.
https://doi.org/10.1182/blood-2021-146236
Published: 2021
Journal Articles

A Phase II Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

Matthew J. Frigault, Kathleen M.E. Gallagher, Marc Wehrli, Betsy Valles, Keagan Casey, Kevin Lindell, Michael Trailor, Hana Cho, Jami L. Brown, Nora K. Horick, Justin Chou, Rhine R. Shen, Simone Filosto, Adrian Bot, Marcela V. Maus
Journal: Blood
Blood (2021) 138 (Supplement 1): 2814.
https://doi.org/10.1182/blood-2021-146927
Published: 2021
Journal Articles

Tisagenlecleucel Demonstrates Safety, Efficacy and CNS Trafficking in Primary CNS Lymphoma

Matthew J. Frigault, Jorg Dietrich, Kathleen M.E. Gallagher, Irene Scarfò, Mark Roschewski, Justin T Jordan, Deborah A. Forst, Scott R Plotkin, Daniella Cook, Keagan Casey, Katelin Katsis, Kevin Lindell, Michael Trailor, Nora Horick, Steven McAfee, Paul V O'Donnell, Thomas R Spitzer, Bimalangshu R Dey, Zachariah Defilipp, Areej El-Jawahri, Tracy Batchelor, Marcela V. Maus, Yi-Bin Chen
Journal: Blood
Blood (2021) 138 (Supplement 1): 258.
https://doi.org/10.1182/blood-2021-148444
Published: 2021